<VariationArchive VariationID="3254787" VariationName="NM_000190.4(HMBS):c.9_33+11del" VariationType="Deletion" Accession="VCV003254787" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2024-07-23" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3413561" VariationID="3254787">
      <GeneList>
        <Gene Symbol="HMBS" FullName="hydroxymethylbilane synthase" GeneID="3145" HGNC_ID="HGNC:4982" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="119084881" stop="119093549" display_start="119084881" display_stop="119093549" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NW_009646203.1" start="106480" stop="106757" display_start="106480" display_stop="106757" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="118955586" stop="118964258" display_start="118955586" display_stop="118964258" Strand="+" />
          </Location>
          <OMIM>609806</OMIM>
          <Haploinsufficiency last_evaluated="2020-01-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HMBS">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-01-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HMBS">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000190.4(HMBS):c.9_33+11del</Name>
      <CanonicalSPDI>NC_000011.10:119085041:TAACGGCAATGCGGCTGCAACGGCGGTGAGTGCTGA:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="119085042" stop="119085077" display_start="119085042" display_stop="119085077" variantLength="36" positionVCF="119085041" referenceAlleleVCF="GTAACGGCAATGCGGCTGCAACGGCGGTGAGTGCTGA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="118955752" stop="118955787" display_start="118955752" display_stop="118955787" variantLength="36" positionVCF="118955751" referenceAlleleVCF="GTAACGGCAATGCGGCTGCAACGGCGGTGAGTGCTGA" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.119085042_119085077del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.119085042_119085077del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.118955752_118955787del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.118955752_118955787del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008093.1" sequenceAccession="NG_008093" sequenceVersion="1" change="g.5166_5201del">
            <Expression>NG_008093.1:g.5166_5201del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_124181.1" sequenceAccession="NG_124181" sequenceVersion="1" change="g.661_696del">
            <Expression>NG_124181.1:g.661_696del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001258209.2" sequenceAccession="NM_001258209" sequenceVersion="2" change="c.-134_-99del">
            <Expression>NM_001258209.2:c.-134_-99del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000190.4" sequenceAccession="NM_000190" sequenceVersion="4" change="c.9_33+11del" MANESelect="true">
            <Expression>NM_000190.4:c.9_33+11del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001258208.2" sequenceAccession="NM_001258208" sequenceVersion="2" change="c.9_33+11del">
            <Expression>NM_001258208.2:c.9_33+11del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1076" sequenceAccession="LRG_1076">
            <Expression>LRG_1076:g.5166_5201del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1076t1" sequenceAccession="LRG_1076t1">
            <Expression>LRG_1076t1:c.9_33+11del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000190.4(HMBS):c.9_33+11del AND Acute intermittent porphyria" Accession="RCV004594970" Version="1">
        <ClassifiedConditionList TraitSetID="387">
          <ClassifiedCondition DB="MedGen" ID="C0162565">Acute intermittent porphyria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-17" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-07-23" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17298216</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27539938</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31044425</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33445488</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="387" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4011" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Acute intermittent porphyria</ElementValue>
                <XRef ID="Acute+Intermittent+Porphyria/187" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008294" DB="MONDO" />
                <XRef ID="234422006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Porphobilinogen deaminase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Uroporphyrinogen synthase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">UPS deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Porphyria, Swedish type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HMBS deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute Porphyria</ElementValue>
                <XRef ID="genomeconnect_14819_622" DB="GenomeConnect, ClinGen" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hydroxymethylbilane Synthase Deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AIP</ElementValue>
                <XRef Type="MIM" ID="176000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5732" />
                <XRef ID="5732" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Acute intermittent porphyria (AIP), an autosomal dominant disorder, occurs in heterozygotes for an HMBS pathogenic variant that causes reduced activity of the enzyme porphobilinogen deaminase. AIP is considered "overt" in a heterozygote who was previously or is currently symptomatic; AIP is considered "latent" in a heterozygote who has never had symptoms, and typically has been identified during molecular genetic testing of at-risk family members. Note that GeneReviews does not use the term "carrier" for an individual who is heterozygous for an autosomal dominant pathogenic variant; GeneReviews reserves the term "carrier" for an individual who is heterozygous for an autosomal recessive disorder and thus is not expected to ever develop manifestations of the disorder. Overt AIP is characterized clinically by life-threatening acute neurovisceral attacks of severe abdominal pain without peritoneal signs, often accompanied by nausea, vomiting, tachycardia, and hypertension. Attacks may be complicated by neurologic findings (mental changes, convulsions, and peripheral neuropathy that may progress to respiratory paralysis), and hyponatremia. Acute attacks, which may be provoked by certain drugs, alcoholic beverages, endocrine factors, calorie restriction, stress, and infections, usually resolve within two weeks. Most individuals with AIP have one or a few attacks; about 3%-8% (mainly women) have recurrent attacks (defined as &gt;3 attacks/year) that may persist for years. Other long-term complications are chronic renal failure, hepatocellular carcinoma (HCC), and hypertension. Attacks, which are very rare before puberty, are more common in women than men. Latent AIP. While all individuals heterozygous for an HMBS pathogenic variant that predisposes to AIP are at risk of developing overt AIP, most have latent AIP and never have symptoms.</Attribute>
                <XRef ID="NBK1193" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301372</ID>
                <ID Source="BookShelf">NBK1193</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2007">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_AcuteHepaticPorphyria.pdf</URL>
                <CitationText>Orphanet, Acute hepatic porphyria neuro-visceral crisis, 2007</CitationText>
              </Citation>
              <XRef ID="79276" DB="Orphanet" />
              <XRef ID="C0162565" DB="MedGen" />
              <XRef ID="MONDO:0008294" DB="MONDO" />
              <XRef Type="MIM" ID="176000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9874085" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2024-07-23">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_000190_4_HMBS_c_9_33_11del" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV005086960" DateUpdated="2024-07-23" DateCreated="2024-07-23" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17298216</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27539938</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31044425</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33445488</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with acute intermittent porphyria (AIP; MIM#176000). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0112 - The condition associated with this gene has incomplete penetrance. AIP is a disease with low clinical penetrance, with hormonal changes and commonly used drugs as triggering factors (PMIDs: 33445488, 27539938). (I) 0211 - Canonical splice site variant without proven consequence on splicing (no functional evidence available). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0505 - Abnormal splicing is predicted by in silico tools and affected nucleotide is highly conserved. (SP) 0701 - Other variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. Multiple variants affecting the same canonical splice donor site, as well as other variants affecting non-canonical nucleotides in the same region, have been reported in patients with acute intermittent porphyria (PMIDs: 31044425, 17298216) . (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1101 - Very strong and specific phenotype match for this individual. (SP) 1206 - This variant has been shown to be paternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HMBS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_21266</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000190.4:c.9_33+11del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="176000" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9874085" TraitType="Disease" MappingType="XRef" MappingValue="176000" MappingRef="OMIM">
        <MedGen CUI="C0162565" Name="Acute intermittent porphyria" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

